Skip to content

Intelligence shared is intelligence strengthened

Regulatory teams track more updates than ever, often working in isolation as they assess impact and determine next steps. Our community brings professionals together to compare perspectives, share experience, and strengthen the decisions that follow. 

Infodesk logo

Community members join to learn how to transform regulatory updates into business value. Most regulatory teams excel at surveillance but struggle with activation. Join other industry experts as they reveal how leading organizations bridge the gap between regulatory intelligence and measurable business outcomes.  

Join to receive early access to the next Regulatory Forum.

Join the community

A shared space for discussion and perspective

This forum provides an opportunity to exchange views and learn from peers. It also explores how regulatory intelligence is managed in practice. This includes monitoring and surveillance, triaging to prioritize information, and evaluation to assess the impact on quality, compliance, manufacturing, or labelling. It also considers action, where teams implement changes based on those evaluations.

What you’ll gain

  • Early access to registration for the next Regulatory Forum.
  • Invitations to virtual forums featuring senior industry figures from many leading life sciences organizations.
  • Practical perspectives on moving from surveillance to structured action, with clarity, accountability, and confidence.
  • Access to forum highlights, recordings, and related resources shared with members.
Webinar screencap

Forums within the community

Regulatory Forums play a central role in the community. Each forum focuses on practical discussion and shared learning, supporting decisions that can be explained, defended, and trusted.

Sessions have brought together senior regulatory leaders to share how they approach intelligence, impact assessment, and follow-through in real organizational settings.

Panel members and hosts at previous forums have included:

Chris Whalley

Pfizer’s Senior Director and Head of Global Regulatory Intelligence and Analysis, also Chair of RAPS Regulatory Convergence Planning Committee

Rüdiger Faust

UCB’s Global Policy and Intelligence Lead

Wai Keng Chai

Global Regulatory Policy Director at Haleon

Lo Ann Thomas

Senior Director of Regulatory Intelligence at AstraZeneca

Norbert De Clercq 

Head Regulatory Intelligence and Systems at GlaxoSmithKline

Karen Ragland

Otsuka’s Head of Regulatory Intelligence

Louis Ginn

Director, Global Regulatory Policy and Intelligence at AstraZeneca

Team of professionals talking in an office and looking at a laptop

Who should join

This community is relevant for professionals responsible for monitoring and understanding regulatory change and supporting confident organizational response.

It’s particularly useful for those assessing regulatory impact, supporting compliance and quality processes, or coordinating follow-through across teams, regardless of formal job title.

Join our Regulatory Community to get early access to the next forum

Joining gives you priority access to registration and announcements for the next Regulatory Forum, before wider promotion begins. Leave your details to stay connected. 

Be part of a growing community

See the community in action

Watch and read about previous forums or hear about new events coming up